Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Table 2
Differentially expressed genes in PBC of breast cancer patients after the 1st cycle of DOX-based chemotherapy versus baseline (before the start of chemotherapy).